Illinois 2023-2024 Regular Session

Illinois House Bill HB2189 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	Public Act 103-0429
2	1		HB2189 EnrolledLRB103 24836 BMS 51168 b HB2189 Enrolled LRB103 24836 BMS 51168 b
3	2		HB2189 Enrolled LRB103 24836 BMS 51168 b
4		-	AN ACT concerning regulation.
5		-	Be it enacted by the People of the State of Illinois,
6		-	represented in the General Assembly:
7		-	Section 1. Short title. This Act may be cited as the Access
8		-	to Affordable Insulin Act.
9		-	Section 5. Definitions. As used in this Act:
10		-	"Department" means the Department of Central Management
11		-	Services.
12		-	"Director" means the Director of Central Management
13		-	Services.
14		-	"Insulin" means a prescription drug that contains insulin.
15		-	"Manufacturer" means a manufacturer engaged in the
16		-	manufacturing of insulin that is self-administered on an
17		-	outpatient basis.
18		-	"Navigator" has the meaning described in Section 1311(i)
19		-	of the Patient Protection and Affordable Care Act, Public Law
20		-	111-148, and further defined through amendments to that Act
21		-	and regulations issued under that Act.
22		-	"Pharmacy" means a pharmacy located in this State.
23		-	"Prescription drug" means a drug that is required by
24		-	federal or State law or rule to be dispensed only by
25		-	prescription or that is restricted to administration only by
26		-	practitioners.
	3	+	1 AN ACT concerning regulation.
	4	+	2 Be it enacted by the People of the State of Illinois,
	5	+	3 represented in the General Assembly:
	6	+	4 Section 1. Short title. This Act may be cited as the Access
	7	+	5 to Affordable Insulin Act.
	8	+	6 Section 5. Definitions. As used in this Act:
	9	+	7 "Department" means the Department of Central Management
	10	+	8 Services.
	11	+	9 "Director" means the Director of Central Management
	12	+	10 Services.
	13	+	11 "Insulin" means a prescription drug that contains insulin.
	14	+	12 "Manufacturer" means a manufacturer engaged in the
	15	+	13 manufacturing of insulin that is self-administered on an
	16	+	14 outpatient basis.
	17	+	15 "Navigator" has the meaning described in Section 1311(i)
	18	+	16 of the Patient Protection and Affordable Care Act, Public Law
	19	+	17 111-148, and further defined through amendments to that Act
	20	+	18 and regulations issued under that Act.
	21	+	19 "Pharmacy" means a pharmacy located in this State.
	22	+	20 "Prescription drug" means a drug that is required by
	23	+	21 federal or State law or rule to be dispensed only by
	24	+	22 prescription or that is restricted to administration only by
	25	+	23 practitioners.
27	26
28	27
29	28
30	29		HB2189 Enrolled LRB103 24836 BMS 51168 b
31	30
32	31
33		-	Section 10. Insulin discount program.
34		-	(a) The Department shall offer a discount program that
35		-	allows participants to purchase insulin at a discounted,
36		-	post-rebate price.
37		-	(b) The discount program shall:
38		-	(1) provide a participant with a card or electronic
39		-	document that identifies the participant as eligible for
40		-	the discount;
41		-	(2) provide a participant with information about
42		-	pharmacies that will honor the discount;
43		-	(3) allow a participant to purchase insulin at a
44		-	discounted, post-rebate price; and
45		-	(4) provide a participant with instructions to pursue
46		-	a reimbursement of the purchase price from the
47		-	participant's health insurer.
48		-	(c) The discount program shall charge a price for insulin
49		-	that allows the program to retain only enough of any rebate for
50		-	the insulin to make the State risk pool whole for providing
51		-	discounted insulin to participants.
52		-	Section 90. The Illinois Insurance Code is amended by
53		-	changing Section 356z.41 as follows:
54		-	(215 ILCS 5/356z.41)
55		-	Sec. 356z.41. Cost sharing in prescription insulin drugs;
	32	+	HB2189 Enrolled- 2 -LRB103 24836 BMS 51168 b HB2189 Enrolled - 2 - LRB103 24836 BMS 51168 b
	33	+	HB2189 Enrolled - 2 - LRB103 24836 BMS 51168 b
	34	+	1 Section 10. Insulin discount program.
	35	+	2 (a) The Department shall offer a discount program that
	36	+	3 allows participants to purchase insulin at a discounted,
	37	+	4 post-rebate price.
	38	+	5 (b) The discount program shall:
	39	+	6 (1) provide a participant with a card or electronic
	40	+	7 document that identifies the participant as eligible for
	41	+	8 the discount;
	42	+	9 (2) provide a participant with information about
	43	+	10 pharmacies that will honor the discount;
	44	+	11 (3) allow a participant to purchase insulin at a
	45	+	12 discounted, post-rebate price; and
	46	+	13 (4) provide a participant with instructions to pursue
	47	+	14 a reimbursement of the purchase price from the
	48	+	15 participant's health insurer.
	49	+	16 (c) The discount program shall charge a price for insulin
	50	+	17 that allows the program to retain only enough of any rebate for
	51	+	18 the insulin to make the State risk pool whole for providing
	52	+	19 discounted insulin to participants.
	53	+	20 Section 90. The Illinois Insurance Code is amended by
	54	+	21 changing Section 356z.41 as follows:
	55	+	22 (215 ILCS 5/356z.41)
	56	+	23 Sec. 356z.41. Cost sharing in prescription insulin drugs;
56	57
57	58
58		-	limits; confidentiality of rebate information.
59		-	(a) As used in this Section, "prescription insulin drug"
60		-	means a prescription drug that contains insulin and is used to
61		-	control blood glucose levels to treat diabetes but does not
62		-	include an insulin drug that is administered to a patient
63		-	intravenously.
64		-	(b) This Section applies to a group or individual policy
65		-	of accident and health insurance amended, delivered, issued,
66		-	or renewed on or after the effective date of this amendatory
67		-	Act of the 101st General Assembly.
68		-	(c) An insurer that provides coverage for prescription
69		-	insulin drugs pursuant to the terms of a health coverage plan
70		-	the insurer offers shall limit the total amount that an
71		-	insured is required to pay for a 30-day supply of covered
72		-	prescription insulin drugs at an amount not to exceed $35
73		-	$100, regardless of the quantity or type of covered
74		-	prescription insulin drug used to fill the insured's
75		-	prescription.
76		-	(d) Nothing in this Section prevents an insurer from
77		-	reducing an insured's cost sharing by an amount greater than
78		-	the amount specified in subsection (c).
79		-	(e) The Director may use any of the Director's enforcement
80		-	powers to obtain an insurer's compliance with this Section.
81		-	(f) The Department may adopt rules as necessary to
82		-	implement and administer this Section and to align it with
83		-	federal requirements.
84	59
85	60
86		-	(g) On January 1 of each year, the limit on the amount that
87		-	an insured is required to pay for a 30-day supply of a covered
88		-	prescription insulin drug shall increase by a percentage equal
89		-	to the percentage change from the preceding year in the
90		-	medical care component of the Consumer Price Index of the
91		-	Bureau of Labor Statistics of the United States Department of
92		-	Labor.
93		-	(Source: P.A. 101-625, eff. 1-1-21.)
	61	+
	62	+	HB2189 Enrolled - 2 - LRB103 24836 BMS 51168 b
	63	+
	64	+
	65	+	HB2189 Enrolled- 3 -LRB103 24836 BMS 51168 b HB2189 Enrolled - 3 - LRB103 24836 BMS 51168 b
	66	+	HB2189 Enrolled - 3 - LRB103 24836 BMS 51168 b
	67	+	1 limits; confidentiality of rebate information.
	68	+	2 (a) As used in this Section, "prescription insulin drug"
	69	+	3 means a prescription drug that contains insulin and is used to
	70	+	4 control blood glucose levels to treat diabetes but does not
	71	+	5 include an insulin drug that is administered to a patient
	72	+	6 intravenously.
	73	+	7 (b) This Section applies to a group or individual policy
	74	+	8 of accident and health insurance amended, delivered, issued,
	75	+	9 or renewed on or after the effective date of this amendatory
	76	+	10 Act of the 101st General Assembly.
	77	+	11 (c) An insurer that provides coverage for prescription
	78	+	12 insulin drugs pursuant to the terms of a health coverage plan
	79	+	13 the insurer offers shall limit the total amount that an
	80	+	14 insured is required to pay for a 30-day supply of covered
	81	+	15 prescription insulin drugs at an amount not to exceed $35
	82	+	16 $100, regardless of the quantity or type of covered
	83	+	17 prescription insulin drug used to fill the insured's
	84	+	18 prescription.
	85	+	19 (d) Nothing in this Section prevents an insurer from
	86	+	20 reducing an insured's cost sharing by an amount greater than
	87	+	21 the amount specified in subsection (c).
	88	+	22 (e) The Director may use any of the Director's enforcement
	89	+	23 powers to obtain an insurer's compliance with this Section.
	90	+	24 (f) The Department may adopt rules as necessary to
	91	+	25 implement and administer this Section and to align it with
	92	+	26 federal requirements.
	93	+
	94	+
	95	+
	96	+
	97	+
	98	+	HB2189 Enrolled - 3 - LRB103 24836 BMS 51168 b
	99	+
	100	+
	101	+	HB2189 Enrolled- 4 -LRB103 24836 BMS 51168 b HB2189 Enrolled - 4 - LRB103 24836 BMS 51168 b
	102	+	HB2189 Enrolled - 4 - LRB103 24836 BMS 51168 b
	103	+	1 (g) On January 1 of each year, the limit on the amount that
	104	+	2 an insured is required to pay for a 30-day supply of a covered
	105	+	3 prescription insulin drug shall increase by a percentage equal
	106	+	4 to the percentage change from the preceding year in the
	107	+	5 medical care component of the Consumer Price Index of the
	108	+	6 Bureau of Labor Statistics of the United States Department of
	109	+	7 Labor.
	110	+	8 (Source: P.A. 101-625, eff. 1-1-21.)
	111	+
	112	+
	113	+
	114	+
	115	+
	116	+	HB2189 Enrolled - 4 - LRB103 24836 BMS 51168 b